Initial treatment of childhood chronic inflammatory demyelinating polyradiculoneuropathy

Muscle and Nerve

Volumn 38, Issue 6, 2008, Pages 1640-1643

  Teasley, Jean E ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b American Association of Neuromuscular & Electrodiagnostic Medicine Rochester   (United States)

Author keywords

Childhood chronic inflammatory demyelinating polyneuropathy; Corticosteroids; Intravenous immunoglobulin

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE;

CATARACT; CHILDHOOD; DISEASE COURSE; DISEASE SEVERITY; DRUG COST; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; GLUCOSE BLOOD LEVEL; GROWTH RETARDATION; HEADACHE; HUMAN; HYPERTENSION; INCREASED APPETITE; INFECTION SENSITIVITY; MALAISE; MENTAL INSTABILITY; MYALGIA; NOTE; OSTEOPOROSIS; PLASMAPHERESIS; POLYRADICULONEUROPATHY; PRIORITY JOURNAL; RISK FACTOR; SIDE EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

ADRENAL CORTEX HORMONES; ADULT; CHILD; CYCLOPHOSPHAMIDE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; METHYLPREDNISOLONE; PLASMA EXCHANGE; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; PREDNISONE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 56749175160     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21058     Document Type: Note

References (9)

1. Connolly A. Chronic inflammatory demyelinating polyneuropathy in childhood. Pediatr Neurol 2001;24:177-183.
2. Dalakas M. Intravenous immune globulin therapy for neurologic diseases. Ann Intern Med 1997;126:721-730.
3. Ettenger R. The practical problems of prednisone in pediatric renal transplant. Transplant Proc 2001;33:989-991.
4. Hattori N, Ichimura M, Aoki S, Nagamatsu M, Yasuda T, Kumazawa K, et al. Clinicopathological features of chronic inflammatory polyradiculoneuropathy in childhood. J Neurol Sci 1998;154:66-71.
5. Katz U, Achiron A, Sherer Y, Shoenfeld Y. Safety of intravenous immunoglobulin (IVIG) therapy. Autoimmun Rev 2007;6:257-259.
6. Nevo Y, Pestronk A, Kornberg A, Connolly A, Yee W, Iqbal I, et al. Childhood chronic inflammatory demyelinating neuropathies: clinical course and long-term follow-up. Neurology 1996;47:98-102.
7. Rossignol E, D'Anjou G, Lapointe N, Haddad E, Vanasse M. Evolution and treatment of childhood chronic inflammatory polyneuropathy. Pediatr Neurol 2007;36:88-94.
8. Ryan M, Grattan-Smith P, Procopis P, Morgan G, Ouvrier R. Childhood chronic inflammatory polyneuropathy: clinical course and long-term outcome. Neuromuscul Disord 2000;10:398-406.
9. Simmons Z, Wald J, Albers J. Chronic inflammatory demyelinating polyradiculoneuropathy in children: long-term follow-up, with comparison to adults. Muscle Nerve 1997;20:1569-1575.